Transforming Pharmaceutical Research With Artificial Intelligence

Miltiadis D. Lytras, Sarah A. Alajlan

$448.95 $359.36

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

IGI Global
29 April 2025

Pharmacology; Pharmaceutical technology; Artificial intelligence

Artificial intelligence (AI) technologies enable researchers to analyze vast amounts of data, identify patterns, and predict potential drug candidates with unprecedented accuracy. By automating time-consuming tasks, AI accelerates the discovery of new therapies while reducing costs and improving outcomes. AI's ability to process complex biological and chemical information paves the way for personalized medicine, where treatments can be tailored to individual patients based on their unique genetic makeup. As AI continues to evolve, its integration into pharmaceutical research may unlock new possibilities in healthcare, from groundbreaking treatments to efficient drug delivery. Transforming Pharmaceutical Research With Artificial Intelligence explores the multifaceted landscape where technology intersects with the pharmaceutical domain. From innovative digital solutions optimizing drug discovery to the integration of artificial intelligence in clinical trials, it examines the evolution of the industry, scrutinizing challenges, showcasing initiatives, and elucidating best practices. This book covers topics such as drug discovery, biomarkers, and precision therapeutics, and is a useful resource for pharmacologists, computer engineers, economists, business owners, medical professionals, academicians, and researchers.

Edited by: Miltiadis D. Lytras, Sarah A. Alajlan
Imprint: IGI Global
Country of Publication: United States [Currently unable to ship to USA: see Shipping Info]
Dimensions: Height: 254mm, Width: 178mm,
ISBN: 9798337309026
Pages: 476
Publication Date: 29 April 2025
Audience: College/higher education , Professional and scholarly , Primary , Undergraduate
Format: Paperback
Publisher's Status: Active

Miltiadis D. Lytras is a visiting researcher at Effat University. Dr Lytras is a world-class expert in the fields of cognitive computing, information systems, technology-enabled innovation, social networks, computers in human behavior, and knowledge management. He is an expert in advanced computer science and management, editor, lecturer, and research consultant, with extensive experience in academia and the business sector in Europe and Asia. He served as the Editor in Chief of the International Journal in Semantic Web and Information Systems. He has co-edited more than 110 high impact factor special issues in ISI/Scopus indexed journals and co-Edited/Authored more than 80 books in international publishers including Elsevier, Emerald, IGI-Global, Springer, etc. Dr Lytras has co-authored more than 120 high impact factor papers in Q1 and Q2, Web of Science and Scopus indexed Journals. Dr. Lytras has a 25 years’ experience on Research and Development projects and grants with significant skills and competencies to the successful conceptualization, financing and implementation of R&D projects with extensive experience in Europe, Middle East, and Far East. He has involved in more than 70 R&D projects overtime. Main areas of expertis Dr. Lytras has hold various senior editorial positions in prestigious journals over time including Editor in Chief and Associate Editor positions.